Evaluation of matrix-assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) for the Identification of Group B Streptococcus.
Group B Streptococcus
MALDI-TOF MS
Rapid diagnostics
Streptococcus agalactiae
Journal
BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768
Informations de publication
Date de publication:
14 Feb 2019
14 Feb 2019
Historique:
received:
18
12
2018
accepted:
06
02
2019
entrez:
16
2
2019
pubmed:
16
2
2019
medline:
1
6
2019
Statut:
epublish
Résumé
Group B Streptococcus (GBS) is a leading cause of neonatal meningitis and sepsis worldwide. Intrapartum antibiotics given to women carrying GBS are an effective means of reducing disease in the first week of life. Rapid and reliable tests are needed to accurately identify GBS from these women for timely intrapartum antibiotic administration to prevent neonatal disease. Many laboratories now use matrix-assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) by direct plating or cell lysis for the identification of GBS isolates. The cell lysis step increases time to results for clinical samples and is more complex to perform. Therefore, we seek to evaluate the sensitivity and specificity of the quicker and more rapid direct plating method in identifying GBS. We directly compared swab isolates analysed by both direct plating and cell lysis method and demonstrated that direct plating has a sensitivity and specificity of 0.97 and 1, respectively, compared to an additional cell lysis step. We demonstrated that MALDI-TOF MS can be successfully used for batch processing by the direct plating method which saves time. These results are reassuring for laboratories worldwide who seek to identify GBS from swabs samples as quickly as possible.
Identifiants
pubmed: 30764872
doi: 10.1186/s13104-019-4119-1
pii: 10.1186/s13104-019-4119-1
pmc: PMC6376729
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
85Subventions
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Organisme : Bill and Melinda Gates Foundation
ID : OPP1153630
Organisme : Thrasher Research Fund
ID : 14485
Références
J Clin Microbiol. 2009 Jul;47(7):2284-7
pubmed: 19403759
Clin Infect Dis. 2009 Aug 15;49(4):543-51
pubmed: 19583519
J Clin Microbiol. 2010 Mar;48(3):900-7
pubmed: 20053859
J Clin Microbiol. 2010 May;48(5):1549-54
pubmed: 20220166
J Clin Microbiol. 2010 May;48(5):1991; author reply 1991-2
pubmed: 20444985
MMWR Recomm Rep. 2010 Nov 19;59(RR-10):1-36
pubmed: 21088663
J Clin Microbiol. 2011 Aug;49(8):2868-73
pubmed: 21613431
J Microbiol Methods. 2011 Aug;86(2):262-5
pubmed: 21663770
Lett Appl Microbiol. 2012 Jul;55(1):40-6
pubmed: 22512320
J Clin Microbiol. 2012 Dec;50(12):3845-52
pubmed: 22993178
J Med Microbiol. 2013 Sep;62(Pt 9):1301-6
pubmed: 23764744
J Clin Microbiol. 2013 Nov;51(11):3711-6
pubmed: 23985919
Int J Infect Dis. 2014 Oct;27:44-8
pubmed: 25220051
Am J Trop Med Hyg. 2015 Mar;92(3):641-7
pubmed: 25601995
J Microbiol Methods. 2015 Jul;114:23-5
pubmed: 25934546
J Clin Microbiol. 2015 Dec;53(12):3926-30
pubmed: 26468502
Front Microbiol. 2015 Nov 05;6:1246
pubmed: 26594208
J Infect. 2016 Mar;72(3):283-94
pubmed: 26763186
Front Microbiol. 2016 Feb 12;7:104
pubmed: 26903983
J Clin Microbiol. 2017 Sep;55(9):2590-2598
pubmed: 28659318
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S100-S111
pubmed: 29117327
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S190-S199
pubmed: 29117331
J Clin Microbiol. 2017 Dec 26;56(1):
pubmed: 29118171